Trial Profile
The effect of omarigliptin on glucose excursion using continuous glucose monitoring in the elderly patients with type2 diabetes
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 20 Jun 2016
Price :
$35
*
At a glance
- Drugs Omarigliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 20 Jun 2016 New trial record